NCT01729676View on ClinicalTrials.gov

Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation

CompletedOBSERVATIONAL
Enrollment

315

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Prostate Cancer
Interventions
DRUG

Degarelix or GnRH agonist

Degarelix or GnRH agonist for treatment of prostate cancer according to physicians current practice

Trial Locations (1)

Unknown

Hôpital Robert Boulin, Libourne

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY